1981
DOI: 10.1002/jps.2600700102
|View full text |Cite
|
Sign up to set email alerts
|

Radiopharmaceuticals Used in Myocardial Imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1984
1984
2017
2017

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 168 publications
(25 reference statements)
0
1
0
Order By: Relevance
“…2,3], although the relatively high radiation dose due to its β' radiation (as well as due to 42 K-impurity generally associated with it) and somewhat high-energy γ-rays are drawbacks. In recent years this radioisotope has been replaced to a great extent by 201 Ή and the 7.6 min β* emitter 38 K. Nevertheless, 43 K is still an interesting radioisotope for in-vitro studies in life sciences and for other tracer applications.…”
Section: Introductionmentioning
confidence: 97%
“…2,3], although the relatively high radiation dose due to its β' radiation (as well as due to 42 K-impurity generally associated with it) and somewhat high-energy γ-rays are drawbacks. In recent years this radioisotope has been replaced to a great extent by 201 Ή and the 7.6 min β* emitter 38 K. Nevertheless, 43 K is still an interesting radioisotope for in-vitro studies in life sciences and for other tracer applications.…”
Section: Introductionmentioning
confidence: 97%